We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Radiotherapy Scheme Effect on PD-L1 Expression for Locally Advanced Rectal Cancer.
- Authors
Boustani, Jihane; Derangère, Valentin; Bertaut, Aurélie; Adotevi, Olivier; Morgand, Véronique; Charon-Barra, Céline; Ghiringhelli, François; Mirjolet, Céline
- Abstract
In locally advanced rectal cancer, radiotherapy (RT) followed by surgery have improved locoregional control, but distant recurrences remain frequent. Although checkpoint inhibitors have demonstrated objective response in several cancers, the clinical benefit of PD-1/PD-L1 blockade remains uncertain in rectal cancer. We collected data from biopsies and surgical specimens in 74 patients. The main objective was to evaluate the impact of neoadjuvant RT and fractionation on PD-L1 expression. Secondary objectives were to study the relation between PD-L1 expression and tumor regression grade (TRG), progression-free survival (PFS), overall survival (OS), and CD8 TILs infiltration. Median rates of cells expressing PD-L1 pre- and post-RT were 0.15 (range, 0–17) and 0.5 (range, 0–27.5), respectively (p = 0.0005). There was no effect of RT fractionation on PD-L1+ cell rates. We found no relation between CD8+ TILs infiltration and PD-L1 expression and no difference between high-PD-L1 or low-PD-L1 expression and TRG. High-to-high PD-L1 expression profile had none significant higher OS and PFS compared to all other groups (p = 0.06). Median OS and PFS were higher in biopsies with >0.08 PD-L1+ cells. High-to-high PD-L1 profile and ypT0-2 were significantly associated with higher OS and PFS. This study did not show the differential induction of PD-L1 expression according to fractionation.
- Subjects
PROGRAMMED death-ligand 1; RECTAL cancer; PROGRAMMED cell death 1 receptors; CELL fractionation; PROGRESSION-free survival; TUMOR grading
- Publication
Cells (2073-4409), 2020, Vol 9, Issue 9, p2071
- ISSN
2073-4409
- Publication type
Article
- DOI
10.3390/cells9092071